With regard to the finding of PU.1 mutations in some AML patients and to the role of PU.1 in B-cell development, we hypothesised that B-cell acute lymphoblastic leukaemia (B-ALL) might similarly harbour genomic abnormalities in the PU.1 gene. This evidence concerns the gene SPI1 and acute lymphoblastic leukemia.